Trial Profile
A Prospective, Double-Blind, Placebo-Controlled Trial Investigating the Efficacy and Safety of SCH 900435 (Org 25935) in Relapse Prevention in Subjects With Alcohol Dependence
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs ORG 25935 (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- Acronyms OH-D
- Sponsors Merck Sharp & Dohme; Merck Sharp & Dohme Corp.
- 24 Jun 2014 New trial record